BR9708979A - Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a protein - Google Patents

Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a protein

Info

Publication number
BR9708979A
BR9708979A BR9708979A BR9708979A BR9708979A BR 9708979 A BR9708979 A BR 9708979A BR 9708979 A BR9708979 A BR 9708979A BR 9708979 A BR9708979 A BR 9708979A BR 9708979 A BR9708979 A BR 9708979A
Authority
BR
Brazil
Prior art keywords
immunogenic complex
protein
preparation
same vaccine
vaccine process
Prior art date
Application number
BR9708979A
Other languages
Portuguese (pt)
Inventor
Hans Binz
Jean-Francois Haeuw
Stefan Svenson
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of BR9708979A publication Critical patent/BR9708979A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BR9708979A 1996-05-07 1997-05-06 Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a protein BR9708979A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9605692A FR2748476B1 (en) 1996-05-07 1996-05-07 IMMUNOGENIC COMPLEX, ITS USE, ITS PREPARATION METHOD AND VACCINE CONTAINING THE SAME
PCT/FR1997/000800 WO1997041888A1 (en) 1996-05-07 1997-05-06 Immunogenic complex, use, method of preparation thereof and vaccine containing same

Publications (1)

Publication Number Publication Date
BR9708979A true BR9708979A (en) 1999-08-03

Family

ID=9491907

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708979A BR9708979A (en) 1996-05-07 1997-05-06 Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a protein

Country Status (9)

Country Link
EP (1) EP0914152A1 (en)
JP (1) JP2000509707A (en)
CN (1) CN1221348A (en)
AU (1) AU733845B2 (en)
BR (1) BR9708979A (en)
CA (1) CA2254084A1 (en)
FR (1) FR2748476B1 (en)
NZ (1) NZ332809A (en)
WO (1) WO1997041888A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2776521B1 (en) * 1998-03-27 2000-12-15 Pf Medicament USE OF P40 ACTIVE CONJUGATES BY NASAL
FR2785542B1 (en) * 1998-11-06 2001-02-09 Pf Medicament USE OF AN ENTEROMACTERY OmpA PROTEIN FOR THE SPECIFIC TARGETING OF A BIOLOGICALLY ACTIVE SUBSTANCE THAT IS ASSOCIATED WITH CELLS PRESENTING ANTIGENS SUCH AS HUMAN DENDRITIC CELLS
US6146902A (en) * 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
FR2789588B1 (en) * 1999-02-17 2001-05-04 Pf Medicament USE OF AN OMPA ENTEROBACTERIA PROTEIN ASSOCIATED WITH AN ANTIGEN IN A PHARMACEUTICAL COMPOSITION FOR GENERATING OR INCREASING ANTIVIRAL, PEST CONTROL OR ANTITUMOR CYTOTOXIC RESPONSE
FR2789902A1 (en) * 1999-02-24 2000-08-25 Pf Medicament Use of enterobacterial outer membrane protein as immunogenic carrier, particularly for contraceptive and anti-cancer vaccines, provides strong humoral response
FR2790959B1 (en) * 1999-03-15 2003-06-27 Pf Medicament USE OF BACTERIAL MEMBRANARY FRACTIONS WITH ADJUVANT EFFECT, THEIR PREPARATION METHODS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2828106A1 (en) * 2001-08-02 2003-02-07 Pf Medicament Composition containing peptide from low molecular weight outer membrane protein, useful for preparing vaccines against infections or cancer
US8598337B2 (en) * 2006-01-13 2013-12-03 Baxter International Inc. Method for purifying polysaccharides
CN107184972B (en) * 2017-06-20 2020-12-01 康希诺生物股份公司 Mycobacterium tuberculosis OS-tb oligosaccharide conjugate and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
FR2682388B1 (en) * 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc PROCESS FOR THE PREPARATION OF AN OLIGOSIDE BY DEPOLYMERIZATION OF A POLYOSIDE DERIVED FROM A PATHOGENIC AGENT, OLIGOSIDE THUS OBTAINED AND ITS USE IN PARTICULAR AS A VACCINE AGENT.
US6153406A (en) * 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
FR2718452B1 (en) * 1994-04-06 1996-06-28 Pf Medicament Element of immunogen, immunogenic agent, pharmaceutical composition and method of preparation.
FR2726472B1 (en) * 1994-11-07 1997-01-31 Pf Medicament CARRIER WITH ADJUVANT EFFECT, IMMUNOGENIC COMPLEX CONTAINING THE SAME, PREPARATION METHOD THEREOF, NUCLEOTIDE SEQUENCE AND VACCINE
FR2726471B1 (en) * 1994-11-07 1997-01-31 Pf Medicament PROCESS FOR IMPROVING THE IMMUNOGENICITY OF AN IMMUNOGENIC COMPOUND OR A HAPTENA AND APPLICATION TO THE PREPARATION OF VACCINES

Also Published As

Publication number Publication date
FR2748476A1 (en) 1997-11-14
EP0914152A1 (en) 1999-05-12
AU2901997A (en) 1997-11-26
WO1997041888A1 (en) 1997-11-13
FR2748476B1 (en) 1998-08-14
NZ332809A (en) 2000-05-26
CN1221348A (en) 1999-06-30
JP2000509707A (en) 2000-08-02
CA2254084A1 (en) 1997-11-13
AU733845B2 (en) 2001-05-31

Similar Documents

Publication Publication Date Title
BR9710182A (en) Ampoule packaging apparatus and process for making an ampoule packaging and use of an ampoule packaging
PT1003478E (en) AQUOSOL AQUOSOL PREPARATIONS CONTAINING BIOLOGICALLY ACTIVE MACROMOLECULES AND PROCESS FOR THE PREPARATION OF THEIR RESPIRATORS
EE9900014A (en) Erythromycins and the process for their preparation
EE03380B1 (en) Pharmaceutical aerosol formulation and process for its preparation
BR9501770A (en) Use of a compound, compound, pharmaceutical formulation and process for preparing a compound
MX9100031A (en) AMINO SILICONE COMPOUNDS AND PROCEDURE FOR THE PREPARATION
EE03778B1 (en) Cancer vaccine and method for its preparation
BR9502471A (en) Guanidine compound Process for preparing a guanidine compound Pharmaceutical composition Use of a guanidine compound Method for the prophylactic or therapeutic treatment of diseases and process for preparing a pharmaceutical composition
FI98529B (en) Method and apparatus for the preparation of light olefins
EE04681B1 (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
BR9504463A (en) Process for preparation of quetoprofen liposomes and pharmaceutical preparations
BR8903705A (en) ARTIFICIAL HAIR FOR HAIR IMPLANT AND PROCESS AND PREPARATION APPARATUS FOR THE SAME
BR9600149A (en) 2- (2-N-alkoxyphenyl) -purin-6-ones 9-substituted process for its medical preparation and use
PT949335E (en) METHOD FOR PREPARING DURING THE PURIFIED DENTURE OF BONE DERIVED FACTOR
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
BR9501678A (en) Preparation and method for hair treatment
BR9708979A (en) Immunogenic complex use of the same vaccine process for the preparation of an immunogenic complex and use of a protein
BR9800557A (en) Continuous process for the preparation of 4-aminopiperidines
BR9400338A (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethane and pentafluorethane
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
BR9601193A (en) Multi-component vaccine and processes for preparing and administering the vaccine
EE9800075A (en) Combined medicinal product, its use and method of its preparation
BR9706239A (en) Process for the preparation of 3- (1-hydroxyphenyl-1-alkoxyimino-methyl) dioxazins
BR9603124A (en) Dipeptide process for preparing the same mixture and drugs
BR9600779A (en) Benzenesulfonylureas and -thioreas substituted process for their preparation, use and medicine

Legal Events

Date Code Title Description
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements